Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Arnab Ghosh, Sham Mailankody, Sergio A. Giralt, C. Ola Landgren, Eric L. Smith & Renier J. Brentjens. (2018) CAR T cell therapy for multiple myeloma: where are we now and where are we headed?. Leukemia & Lymphoma 59:9, pages 2056-2067.
Read now
Read now
Laurent Garderet, Gordon Cook, Holger W. Auner, Benedetto Bruno, Henk Lokhorst, Jose Antonio Perez-Simon, Firoozeh Sahebi, Christof Scheid, Curly Morris, Anja van Biezen, Mohamad Sobh, Mauricette Michallet, Gösta Gahrton, Stefan Schönland & Nicolaus Kröger. (2017) Treatment options for relapse after autograft in multiple myeloma – report from an EBMT educational meeting. Leukemia & Lymphoma 58:4, pages 797-808.
Read now
Read now
Massimo Martino, Anna Grazia Recchia, Roberta Fedele, Santo Neri, Iolanda Donatella Vincelli, Tiziana Moscato, Massimo Gentile & Fortunato Morabito. (2016) The role of tandem stem cell transplantation for multiple myeloma patients. Expert Opinion on Biological Therapy 16:4, pages 515-534.
Read now
Read now
Articles from other publishers (15)
FNU Jyotsna, Jibran Ikram, FNU Nageeta, FNU Komal, FNU Anjlee, Harshkumar Patel, Taleb Nassri, Meena Kumari, Rajesh Kumar, Syeda Urooba Shah, Maham Kashif, Giustino Varrassi, Satesh Kumar & Tirath Patel. (2023) Unlocking the Potential of Immunotherapy in Cardiovascular Disease: A Comprehensive Review of Applications and Future Directions. Cureus.
Crossref
Crossref
R. Frank Cornell & Luciano J. Costa. (2018) The Future of Chimeric Antigen Receptor T Cell Therapy for the Treatment of Multiple Myeloma. Biology of Blood and Marrow Transplantation.
Crossref
Crossref
Ranjit Nair & Krina Patel. (2018) Emerging role of CAR T cell therapy in multiple myeloma. Advances in Cell and Gene Therapy 1:3, pages e22.
Crossref
Crossref
Anthony Oyekunle, Evgenii Shumilov, Philippe Kostrewa, Andreas Burchert, Lorenz Trümper, Patrick Wuchter, Gerald Wulf, Ulrike Bacher & Nicolaus Kröger. (2018) Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens. Biology of Blood and Marrow Transplantation 24:2, pages 276-281.
Crossref
Crossref
Jing Ma, Qian Li, Zhen Yu, Zeng Cao, Su Liu, Lin Chen, Han Li, Shuang Gao, Tinghui Yan, Yafei Wang & Qiang Liu. (2017) Immunotherapy Strategies Against Multiple Myeloma. Technology in Cancer Research & Treatment 16:6, pages 717-726.
Crossref
Crossref
Mattia D’Agostino, Mario Boccadoro & Eric L. Smith. (2017) Novel Immunotherapies for Multiple Myeloma. Current Hematologic Malignancy Reports 12:4, pages 344-357.
Crossref
Crossref
Laurent Garderet, Anita D'Souza, Paulette Jacobs, Anja van Biezen, Stefan Schönland, Nicolaus Kroeger, Curly Morris & Parameswaran Hari. (2017) Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances. Biology of Blood and Marrow Transplantation 23:7, pages 1193-1202.
Crossref
Crossref
Leo Rasche, Niels Weinhold, Gareth J. Morgan, Frits van Rhee & Faith E. Davies. (2017) Immunologic approaches for the treatment of multiple myeloma. Cancer Treatment Reviews 55, pages 190-199.
Crossref
Crossref
Leo Rasche, Christoph Röllig, Gernot Stuhler, Sophia Danhof, Stephan Mielke, Goetz Ulrich Grigoleit, Lea Dissen, Lea Schemmel, Jan Moritz Middeke, Viktoria Rücker, Martin Schreder, Johannes Schetelig, Martin Bornhäuser, Hermann Einsele, Christian Thiede & Stefan Knop. (2016) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biology of Blood and Marrow Transplantation 22:11, pages 1988-1996.
Crossref
Crossref
M Sobh, M Michallet, G Gahrton, S Iacobelli, A van Biezen, S Schönland, E Petersen, N Schaap, F Bonifazi, L Volin, E Meijer, D Niederwieser, J El-Cheikh, R Tabrizi, N Fegeux, J Finke, D Bunjes, J Cornelissen, H Einsele, B Bruno, M Potter, R Fanin, M Mohty, L Garderet & N Kröger. (2016) Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party. Leukemia 30:10, pages 2047-2054.
Crossref
Crossref
Aneta SchieferdeckerAnna OberleBenjamin ThieleFabian HofmannMarkus GöthelSebastian MietheMichael HustFriederike BraigMareike VoigtUte-Marie von PeinFriedrich Koch-Nolte, Friedrich Haag, Malik Alawi, Daniela Indenbirken, Adam Grundhoff, Carsten BokemeyerUlrike Bacher, Nicolaus KrögerMascha Binder. (2016) A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma. Blood 127:25, pages 3202-3214.
Crossref
Crossref
M Ladetto, S Ferrero, D Drandi, M Festuccia, F Patriarca, N Mordini, S Cena, R Benedetto, G Guarona, F Ferrando, L Brunello, P Ghione, V Boccasavia, R Fanin, P Omedè, L Giaccone, A Palumbo, R Passera, M Boccadoro & B Bruno. (2015) Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. Leukemia 30:5, pages 1211-1214.
Crossref
Crossref
Kristy Wahaib, Ashton E. Beggs, Hope Campbell, Leela Kodali & Patrick D. Ford. (2016) Panobinostat: A histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma. American Journal of Health-System Pharmacy 73:7, pages 441-450.
Crossref
Crossref
B Bruno. (2016) Allogeneic transplantation for multiple myeloma: yes, no or maybe?. Bone Marrow Transplantation 51:4, pages 506-507.
Crossref
Crossref
Eirini Katodritou, Sofia Papadaki, Pavlina Konstantinidou & Evangelos Terpos. (2016) Is it possible to cure myeloma without allogeneic transplantation?. Transfusion and Apheresis Science 54:1, pages 63-70.
Crossref
Crossref